taking tirzepatide every other week Dosing: Weekly vs Every-Other-Week Safety How Many Units Is 2.5

CASE A 51-year-old woman with history of DLE, deep vein thrombosis, and hypothyroidism presented with progressive facial hyperpigmentation of one-year duration that had not been treated

There's no published evidence supporting this approach over standard 4-week titration intervals, but it's a clinical judgment call within a provider's scope

Another study, not yet published, is SURMOUNT-OSA, a clinical trial of 52-weeks that examined the efficacy and safety of TZP versus placebo in obese participants and an established OSA diagnosis for treatment of moderate and severe OSA (102)

Ongoing studies are underway in collaboration with Dr